Top Markets
Coin of the day
Dr. Miele Cosmed Group S.A. Dr. Miele Cosmed Group S.A.

Dr. Miele Cosmed Group S.A.

DMG
Kedudukan dalam Saham #24836
Dr. Miele Cosmed Group S.A., founded in 1990 and headquartered in Radom,... Dr. Miele Cosmed Group S.A., founded in 1990 and headquartered in Radom, Poland, is actively involved in the global production and distribution of a diverse array of chemical and cosmetic products. Their extensive portfolio includes personal hygiene items such as shower gels, liquid soaps, and sanitizing gels and sprays, alongside a dedicated range for children encompassing washing and care cosmetics, wet wipes, and laundry detergents. The company also manufactures household cleaning essentials, offering toilet cleaners, toilet blocks, drain openers (in granule and gel form), washing liquids, fabric softening concentrates, and specific agents for kitchen and bathroom cleaning, as well as hand and surface disinfectants. These offerings are prominently marketed under brands like Bobini, Apart, Biophen, Mole, Sofin, Izo, and Izozid. The company officially adopted its current name, Dr. Miele Cosmed Group S.A., in March 2024, having previously operated as Global Cosmed S.A.
Harga Saham
$0.65312925
Modal Pasaran
$56.02M
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
-34.96%
Negara
PL
Perdagangan Dr. Miele Cosmed Group S.A. (DMG)
Hasil untuk Dr. Miele Cosmed Group S.A. (DMG)
Hasil pada Aug 2026 TTM: 0
Menurut laporan kewangan terkini daripada Dr. Miele Cosmed Group S.A., hasil semasa syarikat (TTM) ialah 0. Pada tahun 2026, syarikat memperoleh hasil sebanyak 0 sama dengan hasil pada tahun 2026 iaitu 0. Hasil ialah jumlah pendapatan keseluruhan yang dijana oleh syarikat daripada jualan barangan atau perkhidmatan. Tidak seperti keuntungan, tiada perbelanjaan ditolak.
Sejarah hasil bagi Dr. Miele Cosmed Group S.A. dari 2026 hingga 2026
Hasil pada akhir setiap tahun
Tahun Hasil Ubah
Tidak cukup data untuk tarikh yang disediakan.
Hasil untuk syarikat atau pesaing serupa
Syarikat Hasil Perbezaan Hasil Negara
$87.03B -
US
$51.67B -
FR
$21.05B -
US
$7.28B -
IN
- -
DE